Phreesia, Inc. $PHR Shares Bought by Geode Capital Management LLC

Geode Capital Management LLC raised its position in Phreesia, Inc. (NYSE:PHR) by 1.9% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 1,312,224 shares of the company’s stock after acquiring an additional 24,063 shares during the period. Geode Capital Management LLC owned approximately 2.21% of Phreesia worth $37,351,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. PNC Financial Services Group Inc. increased its stake in shares of Phreesia by 2.8% during the second quarter. PNC Financial Services Group Inc. now owns 19,983 shares of the company’s stock worth $569,000 after acquiring an additional 540 shares during the period. Boston Partners boosted its holdings in Phreesia by 15.2% in the 2nd quarter. Boston Partners now owns 56,520 shares of the company’s stock valued at $1,609,000 after purchasing an additional 7,466 shares in the last quarter. King Luther Capital Management Corp acquired a new position in Phreesia during the 2nd quarter worth approximately $2,359,000. Acadian Asset Management LLC raised its stake in shares of Phreesia by 61.6% during the 2nd quarter. Acadian Asset Management LLC now owns 364,194 shares of the company’s stock worth $10,357,000 after buying an additional 138,877 shares in the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. lifted its holdings in shares of Phreesia by 71.2% in the 2nd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 153,072 shares of the company’s stock valued at $4,356,000 after buying an additional 63,662 shares during the period. Hedge funds and other institutional investors own 92.10% of the company’s stock.

Phreesia Stock Down 0.5%

PHR stock opened at $20.51 on Thursday. The company’s 50 day simple moving average is $22.60 and its 200-day simple moving average is $25.54. The firm has a market capitalization of $1.23 billion, a PE ratio of -48.84 and a beta of 0.74. Phreesia, Inc. has a 12 month low of $18.55 and a 12 month high of $32.76. The company has a debt-to-equity ratio of 0.02, a current ratio of 2.12 and a quick ratio of 2.12.

Phreesia (NYSE:PHR) last posted its quarterly earnings data on Thursday, September 4th. The company reported $0.01 EPS for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.08. The business had revenue of $117.26 million for the quarter, compared to analyst estimates of $116.39 million. Phreesia had a negative return on equity of 8.75% and a negative net margin of 5.35%.The business’s revenue for the quarter was up 14.9% compared to the same quarter last year. During the same quarter last year, the company earned ($0.03) earnings per share. Phreesia has set its FY 2026 guidance at EPS. Equities analysts expect that Phreesia, Inc. will post -1.1 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on PHR. BMO Capital Markets started coverage on Phreesia in a report on Thursday, November 13th. They set an “outperform” rating and a $32.00 price objective on the stock. Truist Financial upped their price target on shares of Phreesia from $35.00 to $36.00 and gave the stock a “buy” rating in a research note on Friday, September 5th. Citigroup reiterated an “outperform” rating on shares of Phreesia in a report on Monday, September 8th. DA Davidson raised shares of Phreesia to a “strong-buy” rating in a report on Monday, September 8th. Finally, Canaccord Genuity Group upped their target price on shares of Phreesia from $34.00 to $38.00 and gave the stock a “buy” rating in a research report on Friday, September 5th. One research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Phreesia presently has a consensus rating of “Moderate Buy” and an average price target of $33.71.

Insider Activity

In other Phreesia news, insider Evan Roberts sold 1,888 shares of Phreesia stock in a transaction that occurred on Friday, October 17th. The shares were sold at an average price of $22.36, for a total value of $42,215.68. Following the completion of the sale, the insider directly owned 724,949 shares of the company’s stock, valued at approximately $16,209,859.64. The trade was a 0.26% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Balaji Gandhi sold 4,183 shares of the stock in a transaction on Tuesday, September 16th. The stock was sold at an average price of $23.28, for a total value of $97,380.24. Following the transaction, the chief financial officer directly owned 99,125 shares in the company, valued at approximately $2,307,630. This represents a 4.05% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 26,174 shares of company stock valued at $603,835 in the last 90 days. Insiders own 5.50% of the company’s stock.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.